| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |